Latest contributions
TAVI for mixed aortic valve disease - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
Join this live educational case focused on TAVI for mixed aortic valve disease, presented by experts from Chest Diseases Hospital in Kuwait City. Learn to differentiate congenital versus acquired bicuspid aortic valve disease using multimodality imaging and understand the impact of bicuspid anatomy on valve sizing...
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
PCR Gulf Valves 2025 Closing Ceremony
30 Sep 2025 – From PCR Gulf Valves 2025
Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.
Tricuspid transcatheter therapies: the game changer
29 Sep 2025 – From PCR Gulf Valves 2025
Explore the evolving landscape of tricuspid transcatheter therapies in this comprehensive session reviewing tricuspid regurgitation etiology, anatomy, and current treatment options. Learn about various transcatheter tricuspid valve intervention devices, their strengths and limitations, and the critical diagnostic and intraprocedural imaging requirements to optimize patient selection and...
Mitral transcatheter edge-to-edge repair - LIVE Case
29 Sep 2025 – From PCR Gulf Valves 2025
This live educational session from Prince Sultan Cardiac Center in Riyadh offers an in-depth look at mitral transcatheter edge-to-edge repair (TEER) with MitraClip. Learn best practices for patient selection, imaging analysis, operator strategies, and witness a live case procedure to optimize clinical outcomes.
LIVE Educational Case from...
PCR Gulf Valves 2025 Opening Ceremony
29 Sep 2025 – From PCR Gulf Valves 2025
Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...
Mastering tricuspid TEER - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 77-year-old male with atrial fibrillation and chronic kidney disease presented with symptomatic severe atrial tricuspid regurgitation.He underwent implantation of two TriClip XTW devices (antero-septal and postero-septal) under general anesthesia, guided by transesophageal echocardiography (TEE).
LIVE Educational Case from Bordeaux University Hospital - Bordeaux, France
Navigate the video...
Precision in mitral TEER
11 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from Bordeaux University Hospital to gain expert insights into mitral transcatheter edge-to-edge repair (TEER). Explore optimal timing and clinical decision-making for mitral regurgitation treatment, and discover how the PASCAL Precision system enhances procedural precision across diverse mitral anatomies. Witness real-time strategies,...
Introducing the team behind PCR Mitral Focus Group
19 Aug 2025
Together with the Mitral Focus Group members, Co-Directors Philipp Lurz and Thomas Modine will work to align knowledge and collaborate globally to improve care for patients with mitral valve disease.
China experience in TAVI evolution
22 May 2025 – From EuroPCR 2025
This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
Innovations in TMVR and Intrepid trial updates
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...
Tailoring transcatheter mitral therapies: a new era
20 May 2025 – From EuroPCR 2025
This session focuses on the evolving landscape of transcatheter mitral valve therapies. Learn about strategic programme development, patient phenotyping to guide device selection and repair versus replacement decisions, and the latest innovations and approvals in transcatheter mitral valve replacement.
Mitral hotline: new devices
20 May 2025 – From EuroPCR 2025
Stay updated on emerging devices in mitral valve repair and replacement with this session covering novel technologies including transcatheter edge-to-edge repair (TEER), posterior leaflet restoration, transfemoral mitral annuloplasty, and a first-in-human transseptal TMVR system. Clinical trial data and early feasibility experiences provide valuable insights into advancing...
How to tailor transcatheter mitral therapies in 2025? A new era
20 May 2025 – From EuroPCR 2025
In this discussion from EuroPCR 2025, Mayra Guerrero, Thomas Modine, and Philipp Lurz explore the evolving landscape of mitral valve treatment.
While transcatheter edge-to-edge repair (TEER) remains a safe and effective approach, it doesn't suit every patient. Alternatives like transcatheter mitral valve replacement (TMVR), annuloplasty, and NeoChord implantation...
EuroIntervention Journal: 20 years of excellence
25 Feb 2025
Join the PCR community as we commemorate a big year for EuroIntervention!
In this video, your peers share why they read EuroIntervention and how it impacts their daily practice.
Author
Author
Author
Author
Author
Author
Author
Author
Author
Author
Author
Advanced imaging in tricuspid TEER - LIVE case
26 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on how to use imaging in tricuspid TEER:
- A 64-year-old male with a history of CABG and COPD, ICD implantation (2013) mitraclip (2018) and poor LV function (25%), presented a torrential functional tricuspid regurgitation. The operators implanted 2...
Turning your idea into a market-ready device - Innovating Medtech
25 Nov 2024 – From PCR London Valves 2024
Have you ever wondered how an idea evolves into a life-changing medical device? This video takes you through the entire journey from clinical need to market-ready solution, highlighting key opportunities and challenges along the way.
Watch it now to learn how to identify the needs that drive...
Breaking barriers in tricuspid valve repair
25 Nov 2024 – From PCR London Valves 2024
What’s driving the future of transcatheter tricuspid valve repair (TTVR)? Dive into the latest breakthroughs with this video!
Gain insights into real-world outcomes from TTVR registries, uncover key findings from the TriCLASP study, explore how TriClip TEER reshapes the right heart, learn how pulmonary hypertension influences TTVR...
Voices of innovation: perspectives from the stakeholders
25 Nov 2024 – From PCR London Valves 2024
Curious about how innovation becomes impact? This video is a must-watch! Discover now what drives medical breakthroughs from concept to reality and explore the perspectives of those shaping the future of healthcare.
You’ll gain insights into the challenges innovators face at every stage—breakthrough ideas, market regulation, and...
Transcatheter mitral valve replacement - Are we there yet?
25 Nov 2024 – From PCR London Valves 2024
Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!
Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...
Innovation for transcatheter tricuspid interventions - LIVE case
24 Nov 2024 – From PCR London Valves 2024
Dive into the world of innovation for transcatheter tricuspid interventions. Discuss the remaining challenges associated with currently available options, capture the central role of imaging guidance, and understand the anatomical selection criteria for transcatheter tricuspid valve replacement. Experience a live case from St. Thomas' Hospital, London,...
Breaking new ground in mitral valve interventions
24 Nov 2024 – From PCR London Valves 2024
What’s shaping the future of mitral valve therapies? This video from PCR London Valves 2024 unveils groundbreaking late-breaking trials that redefine the possibilities in mitral interventions.
You'll explore real-world insights from the OCEAN-Mitral registry on the MitraClip G4, uncover the link between tricuspid regurgitation and 3-year mortality...
Bicuspid disease - All you need to know
16 May 2024 – From EuroPCR 2024
This session is ideal if you want to understand the anatomical features of bicuspid aortic stenosis, learn about the latest post-TAVI clinical outcomes in bicuspid aortic valves, grasp key considerations for TAVI sizing in these cases, and analyze both self-expanding and balloon-expandable TAVI procedures in bicuspid...
Transcatheter tricuspid valve replacement - LIVE case
Recommended by PCR
15 May 2024 – From EuroPCR 2024
An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...
How does the female heart respond to severe aortic stenosis and aortic intervention?
15 May 2024 – From EuroPCR 2024
In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
TAVI and access: alternating is wise
16 Jan 2024 – From GulfPCR-GIM 2023
Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...
Innovations in transcatheter tricuspid valve intervention - LIVE case
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.
- LIVE case: An 81-year-old woman with permanent AF presents a symptomatic torrential TR with right...
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
